# reload+after+2024-01-21 22:40:01.721874
address1§Prama House
address2§267 Banbury Road
city§Oxford
zip§OX2 7HT
country§United Kingdom
phone§44 20 3034 2820
website§https://www.oxcantech.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase  I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.
fullTimeEmployees§7
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Clarissa Ann Sowemimo-Coker', 'age': 42, 'title': 'CEO & Executive Director', 'yearBorn': 1981, 'fiscalYear': 2023, 'totalPay': 215669, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Paul William Smalley', 'age': 50, 'title': 'Finance Director & Executive Director', 'yearBorn': 1973, 'fiscalYear': 2023, 'totalPay': 155159, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Indraneil  Mahapatra', 'age': 43, 'title': 'Co-Founder & Non-Executive Director', 'yearBorn': 1980, 'fiscalYear': 2023, 'totalPay': 249523, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Valentino  Parravicini', 'age': 54, 'title': 'Chief Scientific Officer', 'yearBorn': 1969, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Robin  Bennett', 'title': 'General Counsel & Company Secretary', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Timothy H. Corn FFPM, M.Sc.', 'age': 72, 'title': 'Executive Director & Chief Medical Officer', 'yearBorn': 1951, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.824
currency§GBp
exchange§LSE
quoteType§EQUITY
shortName§OXFORD CANNABINOID TECHNOLOGIES
longName§Oxford Cannabinoid Technologies Holdings Plc
firstTradeDateEpochUtc§1621580400
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§fd7016ab-1236-3362-a5fa-a627280796f9
recommendationKey§none
quickRatio§7.251
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
